🇺🇸 FDA
Patent

US 9046520

Serologic correlates of protection against Bacillis anthracis infection

granted A61KA61K2039/575A61K39/07

Quick answer

US patent 9046520 (Serologic correlates of protection against Bacillis anthracis infection) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/575, A61K39/07, A61P, A61P31/04